Clinical Trial: A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Observational



Official Title: Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation

Brief Summary:

Background:

- Smith-Lemli-Opitz syndrome (SLOS) is a genetic disorder that prevents the body from making enough cholesterol. People who have SLOS often need to take extra cholesterol, either in food or in supplements, for their bodies to work properly. Cholesterol is very important for the brain and nervous system. Therefore SLOS is highly related to autism, mental retardation, and other brain and nervous system disorders. Not much is known about how people with SLOS handle cholesterol and how taking extra cholesterol helps them. A long-term study of people with SLOS will help answer these and other questions.

Objectives:

- To study the effects of a high-cholesterol diet on people with Smith-Lemli-Opitz syndrome.

Eligibility:

- Individuals of any age who have Smith-Lemli-Opitz syndrome.

Design:

  • Participants will have study visits up to two times in the first year and once a year every year after that. Each visit will last between 3 and 5 days.
  • Participants will be screened with a physical exam, medical history, and blood and urine tests.
  • Participants will provide regular blood, urine, stool, saliva, and skin cell samples for testing.
  • Participants will keep track of the foods they eat at home. During the study, they will eat a high-cholesterol diet at all times, except for the second study visit (3 to 6 months after the screening visit). That visit will involve a cholesterol-free diet for 4 weeks.
  • Participants